Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Recent publications

Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial.

Davis K. et al, (2021), Lancet Infect Dis

Publisher Correction: A guide to vaccinology: from basic principles to new developments.

Pollard AJ. and Bijker EM., (2021), Nat Rev Immunol

Diagnosing X-linked Myotubular Myopathy - A German 20-year Follow Up Experience.

Gangfuss A. et al, (2021), J Neuromuscul Dis, 8, 79 - 90

H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells.

Godfrey L. et al, (2021), Leukemia, 35, 90 - 106

SIMON: Open-Source Knowledge Discovery Platform

Tomic A. et al, (2021), Patterns, 2, 100178 - 100178

Use of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) in X-Linked Myotubular Myopathy: Content Validity and Psychometric Performance.

Duong T. et al, (2021), J Neuromuscul Dis, 8, 63 - 77

Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study.

Annoussamy M. et al, (2020), Ann Clin Transl Neurol

RANK links thymic regulatory T cells to fetal loss and gestational diabetes in pregnancy.

Paolino M. et al, (2020), Nature

A guide to vaccinology: from basic principles to new developments.

Pollard AJ. and Bijker EM., (2020), Nat Rev Immunol

Corrigendum: Cytomegalovirus-Mediated T Cell Receptor Repertoire Perturbation Is Present in Early Life (Frontiers in Immunology, (2020), 11, (1587), 10.3389/fimmu.2020.01587)

Attaf M. et al, (2020), Frontiers in Immunology, 11

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Barrett JR. et al, (2020), Nat Med

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Ewer KJ. et al, (2020), Nat Med

Clinical Genomics for the Diagnosis of Monogenic forms of Inflammatory Bowel Disease

Travis S. and UHLIG H., (2020), JPGN

COVID-19 Vaccine Hesitancy in the UK: The Oxford Coronavirus Explanations, Attitudes, and Narratives Survey (OCEANS) II.

Freeman D. et al, (2020), Psychol Med, 1 - 34

Evidence that corticofugal propagation of ALS pathology is not mediated by prion-like mechanism.

Scekic-Zahirovic J. et al, (2020), Prog Neurobiol

Predicting severity of adverse cardiorespiratory effects of morphine in premature infants: a post hoc analysis of Procedural Pain in Premature Infants trial data.

Hartley C. et al, (2020), Br J Anaesth

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Voysey M. et al, (2020), Lancet

A public health ethic should inform policies on COVID-19 immunity passports - Authors' reply.

Brown RCH. et al, (2020), Lancet Infect Dis

MAIT cell activation augments adenovirus vector vaccine immunogenicity

PROVINE N. et al, (2020), Science

Erratum: Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency (Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency (2013) 2 (1–10), (S2162253116301834), (10.1038/mtna.2013.51))

Yin HF. et al, (2020), Molecular Therapy - Nucleic Acids, 22

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?